|
1
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Henriksen A, Dyhl-Polk A, Chen I and
Nielsen D: Checkpoint inhibitors in pancreatic cancer. Cancer Treat
Rev. 78:17–30. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jarroux J, Morillon A and Pinskaya M:
History, discovery, and classification of lncRNAs. Adv Exp Med
Biol. 1008:1–46. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Z, Wang P, Zhang L, Huang C, Gao J,
Li Y and Yang B: Identification of key genes and long noncoding
RNA-associated competing endogenous RNA (ceRNA) networks in
early-onset preeclampsia. Biomed Res Int.
2020:16734862020.PubMed/NCBI
|
|
9
|
Vishnoi A and Rani S: MiRNA Biogenesis and
regulation of diseases: An overview. Methods Mol Biol. 1509:1–10.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu TX and Rothenberg ME: MicroRNA. J
Allergy Clin Immunol. 141:1202–1207. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gibbons HR, Shaginurova G, Kim LC, Chapman
N, Spurlock CF III and Aune TM: Divergent lncRNA GATA3-AS1
regulates GATA3 transcription in T-Helper 2 cells. Front Immunol.
9:25122018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gulbinas A, Berberat PO, Dambrauskas Z,
Giese T, Giese N, Autschbach F, Kleeff J, Meuer S, Büchler MW and
Friess H: Aberrant gata-3 expression in human pancreatic cancer. J
Histochem Cytochem. 54:161–169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo X, Zhou N, Wang L, Zeng Q and Tang H:
Long noncoding RNA GATA3-AS1 promotes cell proliferation and
metastasis in hepatocellular carcinoma by suppression of PTEN,
CDKN1A, and TP53. Can J Gastroenterol Hepatol. 2019:13896532019.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42((Database issue)): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Khachane AN and Harrison PM: Mining
mammalian transcript data for functional long non-coding RNAs. PLoS
One. 5:e103162010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei W, Liu Y, Lu Y, Yang B and Tang L:
LncRNA XIST promotes pancreatic cancer proliferation through
miR-133a/EGFR. J Cell Biochem. 118:3349–3358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J,
Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 lncRNA
antagonizes let-7 microRNAs. Mol Cell. 52:101–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ren J, Fu J, Ma T, Yan B, Gao R, An Z and
Wang D: LncRNA H19-elevated LIN28B promotes lung cancer progression
through sequestering miR-196b. Cell Cycle. 17:1372–1380. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang Q and Hann SS: HOTAIR: An oncogenic
long non-coding RNA in human cancer. Cell Physiol Biochem.
47:893–913. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang YT, Lin TP, Tang JT, Campbell M, Luo
YL, Lu SY, Yang CP, Cheng TY, Chang CH, Liu TT, et al: HOTAIR is a
REST-regulated lncRNA that promotes neuroendocrine differentiation
in castration resistant prostate cancer. Cancer Lett. 433:43–52.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim J, Piao HL, Kim BJ, Yao F, Han Z, Wang
Y, Xiao Z, Siverly AN, Lawhon SE, Ton BN, et al: Long noncoding RNA
MALAT1 suppresses breast cancer metastasis. Nat Genet.
50:1705–1715. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li S, Mei Z, Hu HB and Zhang X: The lncRNA
MALAT1 contributes to non-small cell lung cancer development via
modulating miR-124/STAT3 axis. J Cell Physiol. 233:6679–6688. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang H, Guan Z, He K, Qian J, Cao J and
Teng L: LncRNA UCA1 in anti-cancer drug resistance. Oncotarget.
8:64638–64650. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yao F, Wang Q and Wu Q: The prognostic
value and mechanisms of lncRNA UCA1 in human cancer. Cancer Manag
Res. 11:7685–7696. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Uroda T, Anastasakou E, Rossi A, Teulon
JM, Pellequer JL, Annibale P, Pessey O, Inga A, Chillón I and
Marcia M: Conserved pseudoknots in lncRNA MEG3 are essential for
stimulation of the p53 pathway. Mol Cell. 75:982–995.e9. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang W, Xie Y, Chen F, Liu X, Zhong LL,
Wang HQ and Li QC: LncRNA MEG3 acts a biomarker and regulates cell
functions by targeting ADAR1 in colorectal cancer. World J
Gastroenterol. 25:3972–3984. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang H, Nestor CE, Zhao S, Lentini A,
Bohle B, Benson M and Wang H: Profiling of human CD4+
T-cell subsets identifies the TH2-specific noncoding RNA GATA3-AS1.
J Allergy Clin Immunol. 132:1005–1008. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu YP, Bian XJ, Ye DW, Yao XD, Zhang SL,
Dai B, Zhang HL and Shen YJ: Long noncoding RNA expression
signatures of bladder cancer revealed by microarray. Oncol Lett.
7:1197–1202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gong P, Qiao F, Wu H, Cui H, Li Y, Zheng
Y, Zhou M and Fan H: LncRNA UCA1 promotes tumor metastasis by
inducing miR-203/ZEB2 axis in gastric cancer. Cell Death Dis.
9:11582018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu Y, Zhang X, Hu X, Zhou W, Zhang P,
Zhang J, Yang S and Liu Y: The effects of lncRNA MALAT1 on
proliferation, invasion and migration in colorectal cancer through
regulating SOX9. Mol Med. 24:522018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang L, Guo R, Yuan Z, Shi H and Zhang D:
LncRNA HOTAIR Regulates CCND1 and CCND2 expression by sponging
miR-206 in ovarian cancer. Cell Physiol Biochem. 49:1289–1303.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ding D, Li C, Zhao T, Li D, Yang L and
Zhang B: LncRNA H19/miR-29b-3p/PGRN axis promoted
epithelial-mesenchymal transition of colorectal cancer cells by
acting on wnt signaling. Mol Cells. 41:423–435. 2018.PubMed/NCBI
|
|
34
|
Mao L, Liu S, Hu L, Jia L, Wang H, Guo M,
Chen C, Liu Y and Xu L: MiR-30 family: A promising regulator in
development and disease. Biomed Res Int. 2018:96234122018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang SJ, Yang SY, Wang DD, Chen X, Shen
HY, Zhang XH, Zhong SL, Tang JH and Zhao JH: The miR-30 family:
Versatile players in breast cancer. Tumour Biol.
39:10104283176922042017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xiong Y, Wang Y, Wang L, Huang Y, Xu Y, Xu
L, Guo Y, Lu J, Li X, Zhu M and Qian H: MicroRNA-30b targets Snail
to impede epithelial-mesenchymal transition in pancreatic cancer
stem cells. J Cancer. 9:2147–2159. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Azmi AS, Li Y, Aboukameel A, Muqbil I,
Philip PA and Mohammad RM: DNA-methylation-caused downregulation of
miR-30 contributes to the high expression of XPO1 and the
aggressive growth of tumors in pancreatic ductal adenocarcinoma.
Cancers (Basel). 11:11012019. View Article : Google Scholar
|
|
38
|
Fanis P, Gillemans N, Aghajanirefah A,
Pourfarzad F, Demmers J, Esteghamat F, Vadlamudi RK, Grosveld F,
Philipsen S and van Dijk TB: Five friends of methylated chromatin
target of protein-arginine-methyltransferase[prmt]-1 (chtop), a
complex linking arginine methylation to desumoylation. Mol Cell
Proteomics. 11:1263–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Castle CD, Cassimere EK and Denicourt C:
LAS1L interacts with the mammalian Rix1 complex to regulate
ribosome biogenesis. Mol Biol Cell. 23:716–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ding J, Huang X, Shao N, Zhou H, Lee DF,
Faiola F, Fidalgo M, Guallar D, Saunders A, Shliaha PV, et al:
Tex10 coordinates epigenetic control of super-enhancer activity in
pluripotency and reprogramming. Cell Stem Cell. 16:653–668. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xiang X, Deng L, Xiong R, Xiao D, Chen Z,
Yang F, Liu K and Feng G: Tex10 is upregulated and promotes cancer
stem cell properties and chemoresistance in hepatocellular
carcinoma. Cell Cycle. 17:1310–1318. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xiang X, Xiong R, Yu C, Deng L, Bie J,
Xiao D, Chen Z, Zhou Y, Li X, Liu K and Feng G: Tex10 promotes
stemness and EMT phenotypes in esophageal squamous cell carcinoma
via the Wnt/β-catenin pathway. Oncol Rep. 42:2600–2610.
2019.PubMed/NCBI
|
|
43
|
Shang S, Hua F and Hu ZW: The regulation
of beta-catenin activity and function in cancer: Therapeutic
opportunities. Oncotarget. 8:33972–33989. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ram Makena M, Gatla H, Verlekar D,
Sukhavasi S, K Pandey M and C Pramanik K: Wnt/β-Catenin signaling:
The culprit in pancreatic carcinogenesis and therapeutic
resistance. Int J Mol Sci. 20:42422019. View Article : Google Scholar
|
|
45
|
Jiang S, Miao D, Wang M, Lv J, Wang Y and
Tong J: MiR-30-5p suppresses cell chemoresistance and stemness in
colorectal cancer through USP22/Wnt/β-catenin signaling axis. J
Cell Mol Med. 23:630–640. 2019. View Article : Google Scholar : PubMed/NCBI
|
